Fingers pointing accusingly at man

BioPharma in the News – April 2026

The FDA is escalating its ongoing push for transparency and tougher enforcement, including publicizing complete response letters, seeking new authority over DTC drug advertising, and tightening expectations around external controls in rare disease trials. Don’t miss the latest in the industry. Source: PharmaVoice The FDAโ€™s push for โ€œradical transparencyโ€ is Read more

Obesity Drugs

BioPharma Trends in the News – November 2025

Three recent BioPharma trends are making waves in the industry: breakthroughs in virus imaging for vaccine development, a new FDA pathway to accelerate rare disease treatments, and historic Medicare deals lowering costs for leading obesity and diabetes drugs. Hereโ€™s whatโ€™s shaping the latest in healthcare. Source: DDW.com Researchers have captured Read more

By Jason Shaneyfelt, ago